192 related articles for article (PubMed ID: 20216419)
1. Pharmacologic treatment of atrophic age-related macular degeneration.
Mata NL; Vogel R
Curr Opin Ophthalmol; 2010 May; 21(3):190-6. PubMed ID: 20216419
[TBL] [Abstract][Full Text] [Related]
2. Treatment for atrophic macular degeneration.
Meleth AD; Wong WT; Chew EY
Curr Opin Ophthalmol; 2011 May; 22(3):190-3. PubMed ID: 21427574
[TBL] [Abstract][Full Text] [Related]
3. Update on geographic atrophy in age-related macular degeneration.
Biarnés M; Monés J; Alonso J; Arias L
Optom Vis Sci; 2011 Jul; 88(7):881-9. PubMed ID: 21532519
[TBL] [Abstract][Full Text] [Related]
4. Current drug and molecular therapies for the treatment of atrophic age-related macular degeneration: phase I to phase III clinical development.
Li H; Chintalapudi SR; Jablonski MM
Expert Opin Investig Drugs; 2017 Oct; 26(10):1103-1114. PubMed ID: 28816076
[TBL] [Abstract][Full Text] [Related]
5. [Future methods of treatment in age related macular degeneration].
Turlea C
Oftalmologia; 2012; 56(1):30-5. PubMed ID: 22888684
[TBL] [Abstract][Full Text] [Related]
6. Concordance of disease progression in bilateral geographic atrophy due to AMD.
Fleckenstein M; Adrion C; Schmitz-Valckenberg S; Göbel AP; Bindewald-Wittich A; Scholl HP; Mansmann U; Holz FG;
Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):637-42. PubMed ID: 19797219
[TBL] [Abstract][Full Text] [Related]
7. Erythropoietin as a novel therapeutic agent for atrophic age-related macular degeneration.
Wang ZY; Zhao KK; Song ZM; Shen LJ; Qu J
Med Hypotheses; 2009 Apr; 72(4):448-50. PubMed ID: 19128888
[TBL] [Abstract][Full Text] [Related]
8. The natural history of geographic atrophy, the advanced atrophic form of age-related macular degeneration.
Sunness JS
Mol Vis; 1999 Nov; 5():25. PubMed ID: 10562649
[TBL] [Abstract][Full Text] [Related]
9. Imaging geographic atrophy in age-related macular degeneration.
Göbel AP; Fleckenstein M; Schmitz-Valckenberg S; Brinkmann CK; Holz FG
Ophthalmologica; 2011; 226(4):182-90. PubMed ID: 21865677
[TBL] [Abstract][Full Text] [Related]
10. THE PATHOPHYSIOLOGY OF GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION AND THE COMPLEMENT PATHWAY AS A THERAPEUTIC TARGET.
Boyer DS; Schmidt-Erfurth U; van Lookeren Campagne M; Henry EC; Brittain C
Retina; 2017 May; 37(5):819-835. PubMed ID: 27902638
[TBL] [Abstract][Full Text] [Related]
11. Enlargement of atrophy and visual acuity loss in the geographic atrophy form of age-related macular degeneration.
Sunness JS; Gonzalez-Baron J; Applegate CA; Bressler NM; Tian Y; Hawkins B; Barron Y; Bergman A
Ophthalmology; 1999 Sep; 106(9):1768-79. PubMed ID: 10485549
[TBL] [Abstract][Full Text] [Related]
12. Fundus autofluorescence and fundus perimetry in the junctional zone of geographic atrophy in patients with age-related macular degeneration.
Schmitz-Valckenberg S; Bültmann S; Dreyhaupt J; Bindewald A; Holz FG; Rohrschneider K
Invest Ophthalmol Vis Sci; 2004 Dec; 45(12):4470-6. PubMed ID: 15557456
[TBL] [Abstract][Full Text] [Related]
13. Age-related macular degeneration.
Arden GB
J Br Menopause Soc; 2006 Jun; 12(2):64-70. PubMed ID: 16776857
[TBL] [Abstract][Full Text] [Related]
14. High-resolution spectral domain-OCT imaging in geographic atrophy associated with age-related macular degeneration.
Fleckenstein M; Charbel Issa P; Helb HM; Schmitz-Valckenberg S; Finger RP; Scholl HP; Loeffler KU; Holz FG
Invest Ophthalmol Vis Sci; 2008 Sep; 49(9):4137-44. PubMed ID: 18487363
[TBL] [Abstract][Full Text] [Related]
15. Autologous translocation of the choroid and retinal pigment epithelium in patients with geographic atrophy.
Joussen AM; Joeres S; Fawzy N; Heussen FM; Llacer H; van Meurs JC; Kirchhof B
Ophthalmology; 2007 Mar; 114(3):551-60. PubMed ID: 17324697
[TBL] [Abstract][Full Text] [Related]
16. Fundus autofluorescence and development of geographic atrophy in age-related macular degeneration.
Holz FG; Bellman C; Staudt S; Schütt F; Völcker HE
Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):1051-6. PubMed ID: 11274085
[TBL] [Abstract][Full Text] [Related]
17. [Age-related macular degeneration; therapeutic options].
La Heij EC; Liem AT; Hendrikse F
Ned Tijdschr Geneeskd; 2001 Jul; 145(29):1390-7. PubMed ID: 11494688
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Approaches with Intravitreal Injections in Geographic Atrophy Secondary to Age-Related Macular Degeneration: Current Drugs and Potential Molecules.
Nebbioso M; Lambiase A; Cerini A; Limoli PG; La Cava M; Greco A
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30987401
[TBL] [Abstract][Full Text] [Related]
19. [Age-related macular degeneration].
Benyelles N; Soubrane G
Rev Prat; 2006 Jun; 56(11):1194-201. PubMed ID: 16903520
[TBL] [Abstract][Full Text] [Related]
20. HMG CoA reductase inhibitors (statins): do they have a role in age-related macular degeneration?
Guymer RH; Chiu AW; Lim L; Baird PN
Surv Ophthalmol; 2005; 50(2):194-206. PubMed ID: 15749309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
